MedPath

Intramuscular Pentazocine Versus Rectal Diclofenac for Pain Relief after Caesarean Section.

Not Applicable
Conditions
caeserean section
Registration Number
PACTR202402735520583
Lead Sponsor
DR. ATONGO TERNGU JESSE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
240
Inclusion Criteria

Patients who had caesarean delivery under spinal anesthesia that consented.

Exclusion Criteria

1.Patients who had caesarean delivery under general anesthesia, epidural combined spinal
2.Patients with medical condition known to be potentially exacerbated by non-steroidal anti-inflammatory drugs such as peptic ulcer disease, renal .disease, Asthma liver disease
3.History of allergy to either of the study medications.
4.Patients with bleeding disorder.
5.Any patient who required special post-operative pain control such as sickle cell disease patient.
6.Patients who did not consent to the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)To compare the effectiveness of intramuscular Pentazocine with rectal diclofenac sodium in post caesarean section pain relief.
Secondary Outcome Measures
NameTimeMethod
2)To compare maternal satisfaction with rectal diclofenac sodium and with intramuscular Pentazocine. ;To determine the side effects/adverse effects experienced by patients in the two groups
© Copyright 2025. All Rights Reserved by MedPath